(Q44312549)

English

86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

11

object named as

Hakim Bouterfa

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

François Jamar

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Raffaella Barone

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Isabelle Mathieu

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Stéphan Walrand

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Daniel Labar

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Pascal Carlier

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Joëlle de Camps

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Horst Schran

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

TianLing Chen

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

M Charles Smith

10

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Roelf Valkema

12

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Eric P Krenning

13

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Larry K Kvols

14

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Stanislas Pauwels

15

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

12 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

510-518

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

https://scigraph.springernature.com/pub.10.1007/s00259-003-1117-1

0 references

Studies on renal tubular protein reabsorption: Partial and near complete inhibition by certain amino acids

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

End-stage renal disease after treatment with 90Y-DOTATOC.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The somatostatin receptor-targeted radiotherapeutic [90Y-DOTA-DPhe1, Tyr3]octreotide (90Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biokinetics and dosimetry in patients administered with (111)In-DOTA-Tyr(3)-octreotide: implications for internal radiotherapy with (90)Y-DOTATOC

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Yttrium-90-labelled somatostatin-analogue for cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin analogues for somatostatin-receptor-mediated radiotherapy of cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The ECAT EXACT HR: performance of a new high resolution positron scanner.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of (86)Y-DOTATOC and (111)In-DTPA-octreotide

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uptake kinetics of the somatostatin receptor ligand [86Y]DOTA-DPhe1- Tyr3-octreotide ([86Y]SMT487) using positron emission tomography in non-human primates and calculation of radiation doses of the 90Y-labelled analogue.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitation in PET using isotopes emitting prompt single gammas: application to yttrium-86.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accelerated image reconstruction using ordered subsets of projection data

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Yttrium-90 DOTATOC: first clinical results

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal metabolism of 111In-DTPA-D-Phe1-octreotide in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In situ radiotherapy with 111In-pentetreotide: initial observations and future directions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12582815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-003-1117-1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44312549&oldid=2109363878"